Skip to main content

JHOP - April 2025 Vol 15, No 2

Case Reports
Original Research
HOPA Corner
Case Reports
Case Reports, Gynecologic Cancers, Adverse Events, Checkpoint Inhibitors, Monoclonal Antibodies
Early-Onset, Severe Immune-Mediated Hepatitis With Dostarlimab in a Patient With Endometrial Cancer: A Case Report
Leslie L. Gingo, PharmD, BCPS; Emily E. O’Brien, MD; Alexander B. Olawaiye, MD
Read More
Case Reports, Infections, Monoclonal Antibodies, Multiple Myeloma, Antibiotics, Adverse Events
Listeria Monocytogenes Meningoencephalitis in a Patient Who Received Daratumumab: A Case Report
Megan L. Edwards, PharmD; Micaela N. Warfield, PharmD; Bibek Saha, MD; Pritish K. Tosh, MD, FACP, FIDSA; Ryan W. Stevens, PharmD, BCIDP; Josh Clement, PharmD, BCIDP, AAHIVP
Read More
Original Research
Online First
Original Research, Oncology Pharmacy Programs/Protocols, Cost of Care, Disparities in Oncology Care
Implementation and Evaluation of an Oral Cancer Drug Repository Service at a Community Cancer Center
Joseph Haroney, PharmD, BCPS; Amanda Kogelman, PharmD, BCOP; Chelsea Palmer, CPhT-Adv, CSPT; Aimee Cloud, PharmD, BCOP; Daniel Kroll, PharmD
Read More
Original Research, Chemotherapy, Adverse Events
Mannitol Administration and the Risk for Cisplatin-Induced Nephrotoxicity
Kathryn E.K. Berlin, DO, FAAP; Aniko Szabo, PhD; Bhavna Bhasin-Chhabra, MBBS, MD; Ariel Nelson, MD, MS; Thomas Giever, DO, MBA; Amanda G. Pawlenty, PharmD, BCOP, et al.
Read More
HOPA Corner
Online First
HOPA Corner, Oncology Pharmacy Programs/Protocols
Pursuing Equity: A Strategic Approach to Improving Diversity, Equity, and Inclusion as an Organizational Priority for the Hematology/Oncology Pharmacy Association
Maurice D. Alexander, PharmD; Larry W. Buie, PharmD; Kamakshi V. Rao, PharmD; Eric Chow, PharmD; Ashley Chen, PharmD; Marcus Autry, PharmD, et al.
Read More